ArticleAnnals of hematology2024

Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study.

Yan-Ting Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.